Rosiglitazone attenuates angiotensin II-induced C-reactive protein expression in hepatocytes via inhibiting AT1/ROS/MAPK signal pathway
- PMID: 26741265
- DOI: 10.1016/j.intimp.2015.12.026
Rosiglitazone attenuates angiotensin II-induced C-reactive protein expression in hepatocytes via inhibiting AT1/ROS/MAPK signal pathway
Abstract
Inflammation is a commonly pathological change in liver diseases, and promotes the development of acute and chronic liver diseases by excessive production of inflammatory cytokines. C-reactive protein (CRP) is primarily synthesized in the liver and participates in many chronic diseases. Our previous study confirmed that Ang II stimulates CRP generation in hepatocytes. This study investigated the effect of rosiglitazone (RSG) on Ang II-stimulated CRP expression and the molecular mechanism in hepatocytes. The results showed that the subcutaneous infusion of Ang II to rats for 7days through the osmotic minipumps increased CRP expression in the liver and serum CRP level. The simultaneous treatment of rats with RSG reduced CRP generation in the liver and CRP concentration in serum. Further study showed that RSG down-regulated Ang II-induced mRNA and protein expression of CRP and AT1 as well as phosphorylation of ERK1/2 and JNK, enhanced mRNA and protein expression of PPARγ in hepatocytes in vivo and in vitro. In addition, RSG increased superoxide dismutase activity in the liver of Ang II-infused rats in vivo, and decreased Ang II-stimulated reactive oxygen species (ROS) production in hepatocytes in vitro. In conclusion, the present study demonstrates that RSG is able to inhibit Ang II-induced CRP generation by interfering with AT1-ROS-ERK1/2/JNK signal pathway and up-regulating PPARγ expression in hepatocytes, which provides the new evidence and mechanisms for the beneficial effect of RSG to relieve hepatic inflammation and suggests the possibility that RSG is used for the inflammatory hepatic diseases.
Keywords: Angiotensin II; C-reactive protein; Hepatocytes; Inflammation; Rosiglitazone.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
C-Reactive Protein: The Most Familiar Stranger.J Immunol. 2023 Mar 15;210(6):699-707. doi: 10.4049/jimmunol.2200831. J Immunol. 2023. PMID: 36881905 Review.
-
Epigallocatechin-3-gallate inhibits angiotensin II-induced C-reactive protein generation through interfering with the AT1-ROS-ERK1/2 signaling pathway in hepatocytes.Naunyn Schmiedebergs Arch Pharmacol. 2016 Nov;389(11):1225-1234. doi: 10.1007/s00210-016-1279-6. Epub 2016 Aug 4. Naunyn Schmiedebergs Arch Pharmacol. 2016. PMID: 27492718
-
Emodin Inhibits Homocysteine-Induced C-Reactive Protein Generation in Vascular Smooth Muscle Cells by Regulating PPARγ Expression and ROS-ERK1/2/p38 Signal Pathway.PLoS One. 2015 Jul 1;10(7):e0131295. doi: 10.1371/journal.pone.0131295. eCollection 2015. PLoS One. 2015. PMID: 26131983 Free PMC article.
-
Angiotensin II induces C-reactive protein expression via AT1-ROS-MAPK-NF-κB signal pathway in hepatocytes.Cell Physiol Biochem. 2013;32(3):569-80. doi: 10.1159/000354461. Epub 2013 Sep 6. Cell Physiol Biochem. 2013. PMID: 24021937
-
Rosiglitazone inhibits angiotensin II-induced C-reactive protein production in human aortic endothelial cells through regulating AT(1)-ROS-MAPK signal pathway.Inflamm Res. 2012 Sep;61(9):1031-7. doi: 10.1007/s00011-012-0496-9. Epub 2012 Jun 3. Inflamm Res. 2012. PMID: 22659808
Cited by
-
Interorgan communication with the liver: novel mechanisms and therapeutic targets.Front Immunol. 2023 Dec 12;14:1314123. doi: 10.3389/fimmu.2023.1314123. eCollection 2023. Front Immunol. 2023. PMID: 38155961 Free PMC article. Review.
-
The Ameliorative Effects of Fucoidan in Thioacetaide-Induced Liver Injury in Mice.Molecules. 2021 Mar 30;26(7):1937. doi: 10.3390/molecules26071937. Molecules. 2021. PMID: 33808318 Free PMC article.
-
The Nuclear Export and Ubiquitin-Proteasome-Dependent Degradation of PPARγ Induced By Angiotensin II.Int J Biol Sci. 2019 May 11;15(6):1215-1224. doi: 10.7150/ijbs.29741. eCollection 2019. Int J Biol Sci. 2019. PMID: 31223281 Free PMC article.
-
Rosiglitazone inhibits PM2.5-induced cytotoxicity in human lung epithelial A549 cells.Ann Transl Med. 2018 Apr;6(8):152. doi: 10.21037/atm.2018.04.13. Ann Transl Med. 2018. PMID: 29862241 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous